Lenalidomide-Induced Second Cancer Risk Limited to Multiple Myeloma

No increased risk to patients with other hematologic malignancies, meta-analysis shows

Related Keywords

Houston ,Texas ,United States ,London ,City Of ,United Kingdom ,Massachusetts ,Lenalidomide Revlimid ,Charlotte Pawlyn ,Sarah Bird ,Mike Bassett ,Konstantinos Lontos ,Institute Of Cancer Research ,University Of Texas Md Anderson Cancer ,Cancer ,Royal Marsden Hospital ,Cancer Research ,